Gen-Probe acquisition could boost medical sales jobs

The acquisition of US-based Gen-Probe by Hologic could boost medical sales jobs, it has been suggested.

The $3.7 billion acquisition deal is expected to help both firms to expand their presence in the life sciences industry.

Peter Abair, director of economic and global affairs at the Massachusetts Biotechnology Council, told the Boston Herald the deal may also be positive news for the medical sales jobs market. He is quoted as saying, "Hologic is becoming a bigger and bigger player. It speaks to the health of the company and the industry here."

Under the terms of the deal, Gen-Probe will become a subsidiary of Hologic, firm which specialises in medical devices related to women’s health, such as breast and cervical cancer treatments.

Media reports say that Gen-Probe recently got the go-ahead from the Food and Drug Administration to sell a test which can highlight whether men who have prostate cancer require a biopsy. The firm also sells products such as molecular diagnostic tests for sexually transmitted diseases and West Nile virus.

Rob Cascella, chief executive of Hologic, told the Financial Times, “With the addition of this product line and these products, we feel that we’re positioned to now have a high-growth molecular business and overall diagnostic business.”

He added, "This story is about the growth of two businesses on a faster trajectory.”

http://www.kirkhamyoung.co.uk/news/article/genprobe-acquisition-could-boost-medical-sales-jobs-183446.html